Article: | MedLuna.com

Overview

Journal Can Fam Physician

Specialties General Medicine
Public Health

Date 2022 Feb 18

PMID 35177497

Authors

Zainab Doleeb

Maclite Tesfaye

Amanda Selk

Sheila Dunn

Cynthia Maxwell

Affiliations

Soon will be listed here.

References

Arbyn M, Smith S, Temin S, Sultana F, Castle P . Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ. 2018; 363:k4823. PMC: 6278587. DOI: 10.1136/bmj.k4823. View

Koliopoulos G, Nyaga V, Santesso N, Bryant A, Martin-Hirsch P, Mustafa R . Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 2017; 8:CD008587. PMC: 6483676. DOI: 10.1002/14651858.CD008587.pub2. View

Ogilvie G, van Niekerk D, Krajden M, Smith L, Cook D, Gondara L . Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial. JAMA. 2018; 320(1):43-52. PMC: 6583046. DOI: 10.1001/jama.2018.7464. View

Gupta S, Palmer C, Bik E, Cardenas J, Nunez H, Kraal L . Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs. Front Public Health. 2018; 6:77. PMC: 5900042. DOI: 10.3389/fpubh.2018.00077. View

OByrne P, Musten A, Orser L, Inamdar G, Grayson M, Jones C . At-home HIV self-testing during COVID: implementing the GetaKit project in Ottawa. Can J Public Health. 2021; 112(4):587-594. PMC: 8127455. DOI: 10.17269/s41997-021-00505-8. View

Jin X, Lipold L, Foucher J, Sikon A, Brainard J, Belinson J . Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years. J Gen Intern Med. 2016; 31(11):1338-1344. PMC: 5071282. DOI: 10.1007/s11606-016-3772-5. View

Meggetto O, Jembere N, Gao J, Walker M, Rey M, Rabeneck L . The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study. BJOG. 2021; 128(9):1503-1510. PMC: 8209864. DOI: 10.1111/1471-0528.16741. View

Ferdous M, Lee S, Goopy S, Yang H, Rumana N, Abedin T . Barriers to cervical cancer screening faced by immigrant women in Canada: a systematic scoping review. BMC Womens Health. 2018; 18(1):165. PMC: 6180489. DOI: 10.1186/s12905-018-0654-5. View

Maar M, Burchell A, Little J, Ogilvie G, Severini A, Yang J . A qualitative study of provider perspectives of structural barriers to cervical cancer screening among first nations women. Womens Health Issues. 2013; 23(5):e319-25. PMC: 4111655. DOI: 10.1016/j.whi.2013.06.005. View

10.

Kiran T, Davie S, Singh D, Hranilovic S, Pinto A, Abramovich A . Cancer screening rates among transgender adults: Cross-sectional analysis of primary care data. Can Fam Physician. 2019; 65(1):e30-e37. PMC: 6347308. View

11.

Angus J, Seto L, Barry N, Cechetto N, Chandani S, Devaney J . Access to cancer screening for women with mobility disabilities. J Cancer Educ. 2011; 27(1):75-82. DOI: 10.1007/s13187-011-0273-4. View

12.

Ogilvie G, Nakisige C, Huh W, Mehrotra R, Franco E, Jeronimo J . Optimizing secondary prevention of cervical cancer: Recent advances and future challenges. Int J Gynaecol Obstet. 2017; 138 Suppl 1:15-19. DOI: 10.1002/ijgo.12187. View

13.

Dickinson J, Tsakonas E, Conner Gorber S, Lewin G, Shaw E, Singh H . Recommendations on screening for cervical cancer. CMAJ. 2013; 185(1):35-45. PMC: 3537778. DOI: 10.1503/cmaj.121505. View

14.

Cohen P, Jhingran A, Oaknin A, Denny L . Cervical cancer. Lancet. 2019; 393(10167):169-182. DOI: 10.1016/S0140-6736(18)32470-X. View

15.

Mao C, Kulasingam S, Whitham H, Hawes S, Lin J, Kiviat N . Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening. J Womens Health (Larchmt). 2017; 26(6):609-615. PMC: 5512311. DOI: 10.1089/jwh.2016.5965. View

16.

Malone C, Barnabas R, Buist D, Tiro J, Winer R . Cost-effectiveness studies of HPV self-sampling: A systematic review. Prev Med. 2020; 132:105953. PMC: 7219564. DOI: 10.1016/j.ypmed.2019.105953. View

17.

Cadman L, Waller J, Ashdown-Barr L, Szarewski A . Barriers to cervical screening in women who have experienced sexual abuse: an exploratory study. J Fam Plann Reprod Health Care. 2012; 38(4):214-20. PMC: 3470431. DOI: 10.1136/jfprhc-2012-100378. View

18.

Reisner S, Deutsch M, Peitzmeier S, Hughto J, Cavanaugh T, Pardee D . Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients. PLoS One. 2018; 13(3):e0190172. PMC: 5851532. DOI: 10.1371/journal.pone.0190172. View

19.

Naimer M, Kwong J, Bhatia D, Moineddin R, Whelan M, Campitelli M . The Effect of Changes in Cervical Cancer Screening Guidelines on Chlamydia Testing. Ann Fam Med. 2017; 15(4):329-334. PMC: 5505451. DOI: 10.1370/afm.2097. View